Return to site

Viral Inactivation Market Research Report with Latest Trend, Share, Size, Opportunities For $ 573.0 million Industry

Growth Opportunities in Viral Inactivation

The research report on Viral Inactivation Market provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global viral inactivation market along with the estimates and forecasts of the revenue and market share analysis.

Viral inactivation is an important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses.

Browse and in-depth TOC on “Viral Inactivation Market”

85 — Tables

41 — Figures

130 — Pages

 

Major Drivers For Viral Inactivation Market:

· Rapid Growth in Pharmaceutical and Biotechnology Industries

· Increasing Number of New Drug Launches

· Strong R&D Investments in the Life Sciences Industry

· Increasing Government Support for Pharmaceutical and Biotechnology Industries

· High Incidence and Large Economic Burden of Chronic Diseases

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017

 

The global market is segmented based on method, product, application, end user, and geography.

 

Based on end-user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.

 

Viral Inactivation Market By Application

  • Blood & Blood Products
  • Cellular & Gene Therapy Products
  • Stem Cell Products
  • Tissue & Tissue Products
  • Vaccines and Therapeutics

The major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).

 

Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017

 

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The North America segment is further divided into Canada and the U.S. Asia segment is further divided into China, Japan, India, and Rest of Asia.

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly